3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
Period EndNet income margin (%) YoY (%)
Apr 30, 2025-36.1+547.84%
Apr 30, 2024-5.6-94.73%
Apr 30, 2023-105.7-15.97%
Apr 30, 2022-125.8-35.97%
Apr 30, 2021-196.5-57.33%
Apr 30, 2020-460.5-40.73%
Apr 30, 2019-776.8-4.84%
Apr 30, 2018-816.3+261.01%
Apr 30, 2017-226.1-86.96%
Apr 30, 2016-1,733.9-13.28%
Apr 30, 2015-1,999.4+100.61%
Apr 30, 2014-996.7-60.34%
Apr 30, 2013-2,513.2-7315.56%
Apr 30, 201234.8
AI Chat